前往化源商城

International Journal of Pharmaceutics 2014-10-01

Combining in vitro and in silico methods for better prediction of surfactant effects on the absorption of poorly water soluble drugs-a fenofibrate case example.

Ragna Berthelsen, Erik Sjögren, Jette Jacobsen, Jakob Kristensen, René Holm, Bertil Abrahamsson, Anette Müllertz

文献索引:Int. J. Pharm. 473(1-2) , 356-65, (2014)

全文:HTML全文

摘要

The aim of this study was to develop a sensitive and discriminative in vitro-in silico model able to simulate the in vivo performance of three fenofibrate immediate release formulations containing different surfactants. In addition, the study was designed to investigate the effect of dissolution volume when predicting the oral bioavailability of the formulations. In vitro dissolution studies were carried out using the USP apparatus 2 or a mini paddle assembly, containing 1000 mL or 100mL fasted state biorelevant medium, respectively. In silico simulations of small intestinal absorption were performed using the GI-Sim absorption model. All simulation runs were performed twice adopting either a total small intestinal volume of 533 mL or 105 mL, in order to examine the implication of free luminal water volumes for the in silico predictions. For the tested formulations, the use of a small biorelevant dissolution volume was critical for in vitro-in silico prediction of drug absorption. Good predictions, demonstrating rank order in vivo-in vitro-in silico correlations for Cmax, were obtained with in silico predictions utilizing a 105 mL estimate for the human intestinal water content combined with solubility and dissolution data performed in a mini paddle apparatus with 100mL fasted state simulated media.Copyright © 2014. Published by Elsevier B.V.

相关化合物

结构式 名称/CAS号 全部文献
氢氧化钠 结构式 氢氧化钠
CAS:1310-73-2
氯化钠 结构式 氯化钠
CAS:7647-14-5
甲醇 结构式 甲醇
CAS:67-56-1
3-乙基-2,4-戊烷二酮 结构式 3-乙基-2,4-戊烷二酮
CAS:1540-34-7
非诺贝特 结构式 非诺贝特
CAS:49562-28-9
马来酸 结构式 马来酸
CAS:110-16-7
氯化钠-35cl 结构式 氯化钠-35cl
CAS:20510-55-8